Swiss (SMI) Clinical Research and Equipment Industry Analysis

Industry Valuation and Performance

Has the Swiss Clinical Research and Equipment Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Thu, 16 May 2024	CHF56.3b	CHF10.3b	CHF1.0b	46.2x	56.2x	5.5x
Sat, 13 Apr 2024	CHF55.8b	CHF10.3b	CHF1.0b	43.9x	55.7x	5.4x
Mon, 11 Mar 2024	CHF51.9b	CHF10.2b	CHF995.4m	48.1x	52.1x	5.1x
Wed, 07 Feb 2024	CHF48.0b	CHF10.2b	CHF1.0b	41.5x	47.1x	4.7x
Fri, 05 Jan 2024	CHF41.0b	CHF9.8b	CHF1.5b	31.1x	27.4x	4.2x
Sun, 03 Dec 2023	CHF39.6b	CHF9.8b	CHF1.5b	29.4x	26.5x	4.1x
Tue, 31 Oct 2023	CHF36.4b	CHF9.8b	CHF1.5b	25.3x	24.4x	3.7x
Thu, 28 Sep 2023	CHF45.9b	CHF9.8b	CHF1.5b	31.5x	30.8x	4.7x
Sat, 26 Aug 2023	CHF51.9b	CHF9.8b	CHF1.5b	36x	34.8x	5.3x
Mon, 24 Jul 2023	CHF52.2b	CHF9.8b	CHF1.5b	36.1x	33.7x	5.3x
Wed, 21 Jun 2023	CHF55.6b	CHF9.7b	CHF1.6b	35.3x	34.1x	5.7x
Fri, 19 May 2023	CHF59.4b	CHF9.7b	CHF1.6b	38.1x	36.4x	6.1x
Sun, 16 Apr 2023	CHF61.4b	CHF9.7b	CHF1.7b	42.3x	36.8x	6.3x
Tue, 14 Mar 2023	CHF55.0b	CHF9.6b	CHF1.7b	32.1x	33.1x	5.7x
Thu, 09 Feb 2023	CHF58.6b	CHF9.6b	CHF1.6b	34x	35.8x	6.1x
Sat, 07 Jan 2023	CHF50.3b	CHF9.2b	CHF1.3b	37.4x	37.9x	5.5x
Mon, 05 Dec 2022	CHF54.6b	CHF9.2b	CHF1.3b	41.1x	41.1x	5.9x
Wed, 02 Nov 2022	CHF51.0b	CHF9.2b	CHF1.3b	39.9x	38.3x	5.6x
Fri, 30 Sep 2022	CHF48.4b	CHF9.2b	CHF1.3b	38.2x	37.5x	5.3x
Sun, 28 Aug 2022	CHF55.3b	CHF9.1b	CHF1.3b	43.9x	43.9x	6.1x
Tue, 26 Jul 2022	CHF54.5b	CHF8.9b	CHF1.3b	34.6x	41.5x	6.1x
Thu, 23 Jun 2022	CHF51.2b	CHF8.5b	CHF1.1b	44x	47.5x	6x
Sat, 21 May 2022	CHF56.6b	CHF8.5b	CHF1.1b	46.4x	52.4x	6.7x
Mon, 18 Apr 2022	CHF68.0b	CHF8.5b	CHF1.1b	57x	63.1x	8x
Wed, 16 Mar 2022	CHF65.3b	CHF8.2b	CHF1.1b	49.1x	61.4x	7.9x
Fri, 11 Feb 2022	CHF67.4b	CHF8.0b	CHF1.1b	62.8x	64x	8.4x
Sun, 09 Jan 2022	CHF76.8b	CHF7.4b	CHF929.4m	81.9x	82.6x	10.4x
Tue, 07 Dec 2021	CHF75.0b	CHF7.4b	CHF918.3m	80.2x	81.7x	10.2x
Thu, 04 Nov 2021	CHF82.8b	CHF7.4b	CHF919.0m	76.8x	90.1x	11.2x
Sat, 02 Oct 2021	CHF75.8b	CHF7.4b	CHF920.0m	76.2x	82.4x	10.3x
Mon, 30 Aug 2021	CHF82.2b	CHF7.4b	CHF920.8m	86x	89.2x	11.1x
Tue, 06 Jul 2021	CHF68.3b	CHF7.4b	CHF920.8m	53.6x	74.2x	9.3x

Current Industry PE

Investors are optimistic on the Swiss Life Sciences Tools and Services industry, and appear confident in long term growth rates.

The industry is trading at a PE ratio of 55.1x which is higher than its 3-year average PE of 50.9x.

The 3-year average PS ratio of 6.8x is higher than the industry's current PS ratio of 5.4x.

Past Earnings Growth

The earnings for companies in the Life Sciences Tools and Services industry have remained mostly flat over the last three years.
Meanwhile revenues for these companies have grown 13% per year.
This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Comparison

How does Swiss Clinical Research and Equipment compare with similar industries?


CH Market	2.37%
Healthcare	3.42%
Life Sciences	2.33%
Clinical Research and Equipment	2.33%

Industry PEThere are no additional sub-industries under this industry.

Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

Company	Last Price	7D	1Y	Valuation
BANB Bachem Holding	CHF88.50	8.9% +CHF543.6m	-3.6%	PE59.3x
LONN Lonza Group	CHF532.20	1.1% +CHF418.3m	-5.9%	PE58.7x
TECN Tecan Group	CHF340.40	2.7% +CHF112.7m	-5.7%	PE33x
SFZN Siegfried Holding	CHF884.00	2.9% +CHF107.2m	20.0%	PE33.6x
PPGN PolyPeptide Group	CHF33.55	8.8% +CHF89.0m	41.0%	PS3.5x